Table 6 Putative secretory proteins predicted by ORFpredictor, SignalP, TMHMM and YLoc
Cluster ID | No. of reads | Accession ID | E-value | Description | H. sapiens(Identity) |
|---|---|---|---|---|---|
EPA018LGAA12C000067 | 12 | - | - | - | - |
EPA018LGAA12C000103 | 12 | XP_005104335.1 | 2.98e-09 | PREDICTED: ADP-ribosyl cyclase-like | 25% |
EPA018LGAA12C000011 | 10 | EUB64644.1 | 5.25e-08 | DNA-binding protein HEXBP | 48% |
EPA018LGAA12C000266 | 5 | CCD82741.1 | 2.66e-27 | T-cell immunomodulatory protein | 27% |
EPA018LGAA12C000319 | 5 | ETE62793.1 | 9.78e-51 | Collagen alpha-1(III) chain | 66% |
EPA018LGAA12C000036 | 5 | AFX72984.1 | 0 | Elongation factor 1 alpha | - |
EPA018LGAA12C000355 | 4 | AFI71096.1 | 1.26e-34 | Ag5 | 31% |
EPA018LGAA12C000352 | 4 | - | - | - | - |
EPA018LGAA12C000362 | 4 | - | - | - | - |
EPA018LGAA12C000007 | 4 | - | - | - | - |
EPA018LGAA12C000336 | 4 | - | - | - | - |
EPA018LGAA12C000609 | 3 | - | - | - | - |
EPA018LGAA12C000487 | 3 | CDJ10900.1 | 7.93e-50 | Phospholipase A | 30% |
EPA018LGAA12C000593 | 3 | GAA50115.1 | 3.69e-32 | Ribonuclease Oy | 33% |
EPA018LGAA12C000572 | 3 | CDJ18388.1 | 4.19e-41 | Hypothetical protein EgrG_001045000 | 34% |
EPA018LGAA12C000068 | 3 | - | - | - | - |
EPA018LGAA12C000451 | 3 | CDJ13292.1 | 3.32e-06 | Collagen alpha 2(I) chain | 53% |
EPA018LGAA12C000891 | 2 | XP_003223989.1 | 6.16e-16 | PREDICTED: transforming growth factor-beta-induced protein ig-h3 | 78% |
EPA018LGAA12C000855 | 2 | - | - | - | - |
EPA018LGAA12C000638 | 2 | EUB63160.1 | 1.95e-07 | Murinoglobulin-2 | - |
EPA018LGAA12C000838 | 2 | CDJ18319.1 | 4.40e-24 | Hypothetical protein EgrG_001037900 | - |
EPA018LGAA12C000772 | 2 | - | - | - | - |
EPA018LGAA12S001747 | 1 | - | - | - | - |
EPA018LGAA12S004749 | 1 | CDI70591.1 | 8.15e-42 | Armet protein | 33% |
EPA018LGAA12S003348 | 1 | CDJ11019.1 | 2.28e-10 | Collagen alpha(iv) chain | 56% |
EPA018LGAA12S001839 | 1 | - | - | - | - |
EPA018LGAA12S002027 | 1 | AFM74226.1 | 7.49e-16 | Cysteine-rich with egf-like domains protein | 34% |
EPA018LGAA12S004089 | 1 | CDJ21221.1 | 6.76e-51 | Leucine rich repeat typical subtype | 33% |
EPA018LGAA12S003220 | 1 | - | - | - | - |
EPA018LGAA12S002557 | 1 | CDJ24800.1 | 1.67e-54 | Heat shock protein DnaJ N terminal | 56% |
EPA018LGAA12S003645 | 1 | CDJ12970.1 | 1.81e-23 | Type II collagen B | 38% |
EPA018LGAA12S000676 | 1 | - | - | - | - |
EPA018LGAA12S003769 | 1 | - | - | - | - |
EPA018LGAA12S004845 | 1 | - | - | - | - |
EPA018LGAA12S000743 | 1 | - | - | - | - |
EPA018LGAA12S000277 | 1 | - | - | - | - |
EPA018LGAA12S001291 | 1 | CAJ00244.1 | 2.87e-11 | TPA: endonuclease-reverse transcriptase | - |
EPA018LGAA12S000397 | 1 | AAM82156.1 | 1.03e-11 | AF523312_1 oncosphere-specific antigen | 42% |
EPA018LGAA12S003589 | 1 | XP_007441014.1 | 5.03e-28 | PREDICTED: c-C motif chemokine 4-like | 46% |